Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
adenosine, Air, Alto, AMBITION, angina, answer, apadenoson, ASC, authoritative, backup, banker, binodenoson, borne, calcium, cap, cardiology, cayston, Chairman, characteristic, CHMP, cobicistat, Codification, Commonwealth, commuter, complicated, conditionally, constituted, containP, coronary, CV, Department, diastolic, distinct, dossier, drafting, drew, ejection, element, Emtiva, Epivir, exert, extinguish, extinguished, finite, fundamental, furniture, GAAP, gas, grafting, Greek, greenhouse, heard, highest, Hong, hydrochloride, hypertriglyceridemia, Impending, Indemnity, ineffective, Inspector, intervention, IOCB, kevin, King, Kong, leave, lexiscan, lofton, Luxembourg, mandatory, meantime, Menarini, MPI, myocardial, Nonstatutory, Obama, occurrence, OCI, official, onward, owing, Palo, payer, perfusion, pharmacologic, plasma, predominantly, protest, Quad, qualitative, qualitatively, quantitative, radionuclide, ranexa, ranolazine, reassessment, regadenoson, reliant, revaluation, rilpivirine, Russia, SA, secondary, similarly, Singapore, SPC, stable, strive, subordinated, succeeding, surgical, tadalafil, thereunder, thirteen, thirty, top, unapproved, undergo, undistributed, USP, visibility, warranty, worker, XBRL
Removed:
Achillion, AG, allocation, APB, approximated, Attorney, averaging, bacteria, banking, Biotech, budget, collectibility, comparative, concurrently, custom, deficit, Degussa, demolition, derecognition, description, dismissed, division, documented, EITF, emerging, encompassed, epoprostenol, equally, expensing, extremely, factor, feedback, FIN, flolan, Francisco, French, grouped, HCV, holdback, hypertensive, iloprost, impede, implicated, inclusion, infusion, initiated, lacked, load, lowest, lung, moderated, mutually, natural, newly, Nonmonetary, nonqualified, nonvested, oncology, orally, Ortho, outlined, payor, pegaptamib, people, pharmacy, planned, predecessor, preexisting, preliminary, preparing, prescribe, presence, proceed, Productive, profile, propanoic, prostacyclin, purported, purpose, Raylo, recover, refined, reflection, Remodulin, respond, scleroderma, shared, spectrum, stage, stepped, sterile, successor, Task, threat, transition, treprostinil, twelve, USAID, vote, warranting
Filing tables
Filing exhibits
- 10-K Annual report
- 10.16 Form of Employee Stock Option Agreement Used Under 2004 Eip
- 10.26 Form of Performance Share Award Agreement Used Under the 2004 Eip
- 10.29 Gilead Sciences, Inc. Employee Stock Purchase Plan
- 10.35 Gilead Sciences, Inc. Severance Plan
- 21.1 Subsidiaries of Registrant
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of CEO, As Required by Rule 13A-14(A) or Rule 15D-14(A)
- 31.2 Certification of CFO, As Required by Rule 13A-14(A) or Rule 15D-14(A)
- 32.1 Certifications of CEO and CFO, As Required by Rule 13A-14(B) or Rule 15D-14(B)
- Download Excel data file
- View Excel data file
Related press release
GILD similar filings
Filing view
External links